Fundraising Fox

David Fallace

Investor

Managing Partner at Cure Ventures

Massachusetts

Writes $100K – $5M checks Β· typically $1.5M

About

Managing Partner and Co-Founder of Cure Ventures with over 20 years investing in venture and alternative asset funds. Previously advised Polaris Partners and held roles at TIFF Investment Management, the Alaska Permanent Fund and GF Private Equity Group.

Experience

  1. Cure VenturesManaging Partner and Co-foundercurrent2021 β€” presentBoston, Massachusetts, United States
  2. Polaris PartnersAdviser2018 β€” 2019Boston, Massachusetts
  3. The Investment Fund for FoundationsManaging Director2016 β€” 2017Greater Boston
  4. Codiak BiosciencesInvestor2015 β€” 2016Greater Boston
  5. Denali TherapeuticsBoard Observer2015 β€” 2016San Francisco Bay Area
  6. Alaska Permanent Fund CorporationDirector - Special Opportunities2013 β€” 2016Juneau, Alaska
  7. Juno TherapeuticsBoard Observer2013 β€” 2014Greater Seattle Area
  8. Haugen Financial SystemsVice President2009 β€” 2013
  9. GF Private Equity GroupVice President2000 β€” 2009

Education

  1. University at Buffalo School of Management, The State University of New YorkMBA, Finance1994 β€” 1999
  2. University at Buffalo School of LawJuris Doctor, Tax and Financial Transactions1994 β€” 1998

Skills & more

Private Equity50Portfolio Management35Hedge Funds25Real Estate10Alternative Investments27Venture Capital43Asset Management16Asset Allocation1Corporate Development1Derivatives1Asset Managment3Emerging Markets1

From David's professional profile.

Same school

Shared employers

Deals Β· 2

Tasca Therapeutics CorpBoard seat

via Cure Ventures Β· filed Dec 2025 Β· $70.2M raise

RYNE Biotechnology Inc.Board seat

via Cure Ventures Β· filed Mar 2024 Β· $81.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Cure Ventures

Network5

Investors connected to David in public investor directories β€” a warm-intro map.